Featured Stories
Strengthening Our Leadership Team
HR Director Maja Rojšek Joins the Management Board
With her strong focus on people and culture, she will bring the HR perspective even closer to our strategic decisions.
Read More
INTERVIEW WITH MAJA STRNAD CESTAR, DIRECTOR OF MEDIS
Knowledge Connects Generations
How does Medis promote talent and team spirit? CEO Maja Strnad Cestar provides insights into successful HR strategies.
Read More
CALL FOR ENTRIES
The 12th International Medis Awards Opens
Researchers from nine fields who have published their scientific articles in reputable international journals can apply.
Read More
APPROVED IN EU
EU Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
Italfarmaco is now working closely with national authorities and distribution partners to facilitate timely access to Duvyzat across the EU.
Read More
Interview with our CEO Maja Strnad Cestar for Bulgarian weekly Kapital
We Bring Innovative Therapies Closer to Bulgarian Patients
We have been present in the Bulgarian market since 2017 through our local company, Medis Pharma Bulgaria, offering a broad and diversified portfolio.
Read More
Positive CHMP Opinion
CHMP recommends EU approval for Duvyzat to treat Duchenne muscular dystrophy
If approved by the European Commission, Duvyzat will be available for individuals with DMD aged six years and older who are able to walk.
Read More